Table 1.
Comparison of absolute CD4 count and human immunodeficiency virus viral load in groups of patients with varying hemoglobin level
| Hemoglobin count | Absolute CD4 count (%) | HIV viral load (%) | ||||||
|---|---|---|---|---|---|---|---|---|
| >500 cells/mm3 | 200-500 cells/mm3 | <200 cells/mm3 | P | >200 copies/ml | 200-1000 copies/ml | <1000 copies/ml | P | |
| Treatment naïve (g/dl) | ||||||||
| >12 | 17 (39.5) | 13 (30.2) | 13 (30.2) | 0.008** | 29 (67.4) | 1 (2.3) | 13 (30.2) | 0.000** |
| 10-12 | 3 (15.8) | 3 (15.8) | 13 (68.4) | 6 (31.6) | 0 | 13 (68.4) | ||
| 8-10 | 0 | 3 (23.1) | 10 (76.9) | 0 | 0 | 13 (100.0) | ||
| <8 | 0 | 2 (33.3) | 4 (66.7) | 0 | 1 (16.7) | 5 (83.3) | ||
| On HAART (g/dl) | ||||||||
| >12 | 21 (39.6) | 14 (26.4) | 18 (34.0) | 0.004** | 38 (71.7) | 1 (1.9) | 14 (26.4) | 0.000** |
| 10-12 | 5 (22.7) | 4 (18.2) | 13 (59.1) | 9 (40.9) | 0 | 13 (59.1) | ||
| 8-10 | 0 | 3 (16.7) | 15 (83.3) | 1 (5.6) | 0 | 17 (94.4) | ||
| <8 | 0 | 2 (28.6) | 5 (71.4) | 0 | 1 (14.3) | 6 (85.7) | ||
**P<0.05 is considered to be statistically significant. HAART=Highly active antiretroviral therapy; HIV=Human immunodeficiency virus